Compounds > angiotensin ii, des-phe(8)-
Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Blood Loss, Surgical

angiotensin ii, des-phe(8)- has been researched along with Blood Loss, Surgical in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
D'Armiento, JM; Eiseman, KA; Elisman, K; Fonseca, LD; Gerber, A; Goldklang, MP; Wagener, G1

Trials

1 trial(s) available for angiotensin ii, des-phe(8)- and Blood Loss, Surgical

ArticleYear
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
    Critical care (London, England), 2022, 07-28, Volume: 26, Issue:1

    Topics: Angiotensin I; Antifibrinolytic Agents; Blood Loss, Surgical; COVID-19; Double-Blind Method; Humans; Peptide Fragments; Pilot Projects; Tranexamic Acid; Treatment Outcome

2022